CCCC
C4 THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
C4 THERAPEUTICS INC (CCCC) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$26.93M; the largest are Ken Griffin, Renaissance Technologies, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders41 also report options
Congress trades0
Price$3.13vs quarter-end-32.98%
Sectors0
This quarter's moves
Top holderNew0
Added2
Trimmed / sold2
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $336.7K— of portfolio72,1002026 Q2
Value $114.9K— of portfolio24,6002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $336.7K | — | — |
| Ken GriffinCALL | $114.9K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.